Effect of dry needling on scar tissue
The Effectiveness of Dry Needling in Treating Linear Hypertrophic Scar Tissue: a Randomized Sham-controlled Trial
NA · Iran University of Medical Sciences · NCT06033430
This study is testing whether dry needling can help improve the flexibility and comfort of thick scar tissue for people dealing with this issue.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 20 Years to 60 Years |
| Sex | All |
| Sponsor | Iran University of Medical Sciences (other) |
| Locations | 2 sites (Bethesda, Maryland and 1 other locations) |
| Trial ID | NCT06033430 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of dry needling as a treatment for hypertrophic scar tissue. It is a two-centered, randomized, single-blind, sham-controlled trial involving eighty participants who will be assigned to either a true dry needling group or a sham treatment group. The primary focus is on measuring the compliance of scar tissue, while secondary outcomes include assessing range of motion, pain levels, and functional disability. Participants will undergo a thorough intake process to gather demographic and scar-related information before treatment.
Who should consider this trial
Good fit: Ideal candidates are adults aged 20 to 60 with linear hypertrophic scar tissue that is at least six weeks old and does not restrict joint mobility.
Not a fit: Patients with needle phobia, immature or keloid scars, skin infections, diabetes, or those on anticoagulant medications may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the flexibility and functionality of scar tissue, enhancing patients' quality of life.
How similar studies have performed: While the effectiveness of dry needling for scar tissue is debated, similar studies have shown promising results in improving myofascial tightness.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Linear hypertrophic scar tissue with an age of more than six weeks * No restrictions on active and passive joint range of motion near the scar tissue * Age between 20 and 60 years Exclusion Criteria: * Needle phobia * Immature scar or keloid scar * Skin diseases or infections near the scar tissue * Diabetes * Fractures that have altered joint mobility * Anticoagulant medication use
Where this trial is running
Bethesda, Maryland and 1 other locations
- Myopain Seminars — Bethesda, Maryland, United States (RECRUITING)
- School of Rehabilitation Sciences, Iran University of Medical Sciences — Tehran, Iran, Islamic Republic of (RECRUITING)
Study contacts
- Study coordinator: Mohammadreza Pourahmadi, Ph.D. Postdoc research fellow
- Email: pourahmadipt@gmail.com
- Phone: +989122245593
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Scar Tissue, Hypertrophic Scar, Hypertrophic Scar of Upper Arm, Hypertrophic Surgical Scar, Dry Needling, Hypertrophic scar, Dry needling, Randomized sham-controlled trial